FDA Warning on Botox use
(Reported in Dental Tribune dated Feb 29th, 2008)
The US
Food and Drug Administration has notified the public
that Botox and Botox Cosmetic (Botulinum toxin Type A) and
Myobloc (Botulinum toxin Type B) have been linked in some cases
to adverse reactions, including respiratory failure and death,
following treatment of a variety of conditions using a wide
range of doses.
The agency said the reactions may be related to overdosing.
There is no evidence that these reactions are related to any
defects in the products.
The adverse reactions appear to be related to the spread
of the toxin to areas distant from the site of the injection,
and mimic symptoms of botulism, which may include difficulty
swallowing, weakness and breathing problems.
The FDA is not advising health care professionals to
discontinue prescribing these products.
Remember : at the Henry Shaw Clinic in Winscombe North Somerset,
we do NOT use Botox but recommend an alternative Lip
Enhancement product. For more information, please don't hesitate to contact
us.
|
